[1]
C. Arber, “Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data”, Swiss Med Wkly, vol. 154, no. 10, p. 3704, Oct. 2024.